[1] 韩济生.神经科学原理(第二版).北京:北京医科大学出版社,1999.1137.
[2] Bonne O, Louzoun Y, Aharon I, et al. Cerebral blood flow in depressed Patients:a methodological comparison of statistical parametric mapping and region of interest analyses. Psychiatry Res, 2003, 122(1):49-57.
[3] Smith DJ, Cavanagh JT. The use of single photon emission computed tomography in depressive disorders. Nucl Med Commun,2005, 26(3):197-203.
[4] Ohgami H, Nagayama H, Akiyoshi J, et al. Contributing factors to changes of cerebral blood flow in major depressive Disorder. J Affect Disord, 2005, 87(1):57-63.
[5] Benabarre A,Vieta E, Martin F, et al. Clinical value of 99mTc-HMPAO SPECT in depressed bipolar Ⅰ patients. Psychiatry Res,2004, 132(3):285-289.
[6] Skaf CR, Yamada A, Garrido GE. Psychotic symptoms in major depressive disorder are associated with reduced regional cerebral blood flow in the subgenual anterior cingulated cortex:a voxelbased single photon emission computed tomography (SPECT)study. J Affect Disord, 2002, 68(2-3):295-305.
[7] Cho MJ, Lyoo IK, Lee DW, et al. Brain single photon emission computed tomography findings in depressive pseudodementia patients. J Affect Disord, 2002, 69(1-3):159-166.
[8] Gonul AS, Kula M, Bilgin AG, et al. The regional cerebral blood flow changes in major depressive disorder with and without psychotic features. Prog Neuro Psychopharmacol Biol Psychiatry, 2004,28(6):1015-1021.
[9] American Psychiatric Association. Diagnostic and dtatistical manual of mental disorders. 4th edition, Washington DC:American Psychiatric Association, 1994.
[10] Bonne O, Krausz Y, Gorfine M, et al. Cerebral hypoperfusion inmedication resistant depressed patients assessed by Tc-99m HMPAO SPECT. J Affect Disord, 1996, 41(3):163-171.
[11] Drevets WC, Gadde K, Krishnan R. Neuroimaging studies of depression. In:Charney DS, Netsler EJ,Bunney BJ, (editors):Neurobiology of Mental Illness. New York:Oxford Press, 1999.394-418.
[12] Drevets WC. Neuroimaging studies of mood disorders. Biol Psychiatry, 2000, 48(8):813-829.
[13] Perico CA, Skaf CR, Yamada A, et al. Relationship between regional cerebral blood flow and separate symptom clusters of major depression:a single photon emission computed tomographystudy using statistical parametric mapping. Neurosci Lett,2005, 384(3):265-270.
[14] Navano V, Gasto C, Lomena F, et al. Frontal cerebral perfusion after antidepressant drug treatment versus ECT in elderly patients with major depression:A 12-month follow-up control study. J Clin Psychiatry, 2004, 65(5):656-661.
[15] Davies J, Lloyd KR, Jones IK, et al. Changes in regional cerebral blood flow with venlafaxine in the treatment of major depression.Am J Psychiatry, 2003,160(2):374-376.
[16] Mottaghy FM, Keller CE, Gangitano M, et al. Correlation of cerebral blood flow and treatment effects of repetitive transcranial magnetic stimulation in depressed patients. Psychiatry Res, 2002, 115(1-2):1-14.
[17] Navarro V, Gasto C, Lomena F, et al. Normalization of frontal cerebral perfusion in remitted elderly major depression:12-month follow-up study. Neuroimaging, 2002, 16(3-p1):781-787.
[18] Klimke A, Larisch R, Janz A, et al. Dopamine D2 receptor binding before and after treatment of major depression measured by [123I]IBZM SPECT. Psychiatry Res, 1999, 90(2):91-101.
[19] Brunswick DJ, Amsterdam JD, Mozley PD, et al. Greater availablity of brain dopamine transporters in major depression shown by 99mTc-TRODAT-1 SPECT imaging. Am J Psychiatry, 2003, 160(10):1836-1841.
[20] Malison RT, Price LH, Berman R, et al. Reduced brain serotonin transporter availability in major depression as measured by [123I]-2beta-carbomethoxy-3 beta-(4-iodophenyl) tropane and single photon emission computed tomography. Biol Psychiatry, 1998, 44(11):1090-1098.
[21] Willeit M, Praschak-Rieder N, Neumeister A, et al.[123I]-β-CIT SPECT imaging shows reduced brain serotonin transporter availability in drug-free depressed patients with seasonal affective disorder.Biol Psychiatry, 2000, 47(6):482-489.
[22] Staley JK, Sanacora G, Tamagnan G, et al. Sex differences in diencephalons serotonin transporter availability in major depression. Biol Psychiatry, 2006, 59(1):40-47.
[23] De Win MM, Reneman L, Reitsma JB, et al. Mood disorders and serotonin transporter density in ecstasy users-the influence of long-term abstention, dose, and gender. Psychopharmacology, 2004, 173(3-4):376-382.
[24] Newberg AB, Amsterdam JD, Wintering N, et al. 123I-ADAM binding to serotonin transporters in patients with major depression and healthy controls:a preliminary study. J Nucl Med, 2005, 46(6):973-977.
[25] Schins A, Van Kroonenburgh M, Van laere K, et al. Increased cerebral serotonin-2A receptor binding in depressed patients with myocardial infarction. Psychiatry Res, 2005, 139(2):155-163.